147 related articles for article (PubMed ID: 25860956)
1. Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) is associated with poor prognosis in gastric cancer.
Wang D; Li T; Ye G; Shen Z; Hu Y; Mou T; Yu J; Li S; Liu H; Li G
PLoS One; 2015; 10(4):e0122697. PubMed ID: 25860956
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
3. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis.
Sakellariou S; Fragkou P; Levidou G; Gargalionis AN; Piperi C; Dalagiorgou G; Adamopoulos C; Saetta A; Agrogiannis G; Theohari I; Sougioultzis S; Tsioli P; Karavokyros I; Tsavaris N; Kostakis ID; Zizi-Serbetzoglou A; Vandoros GP; Patsouris E; Korkolopoulou P
BMC Cancer; 2016 Mar; 16():174. PubMed ID: 26931562
[TBL] [Abstract][Full Text] [Related]
6. Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma.
Tateno T; Ueno S; Hiwatashi K; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Sakoda M; Kubo F; Ishigami S; Shinchi H; Natsugoe S
Ann Surg Oncol; 2009 Feb; 16(2):440-6. PubMed ID: 19023628
[TBL] [Abstract][Full Text] [Related]
7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
8. Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients.
Jiang YX; Li PA; Yang SW; Hao YX; Yu PW
Int J Clin Exp Pathol; 2015; 8(6):7002-8. PubMed ID: 26261590
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
10. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
11. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
12. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer.
Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255
[TBL] [Abstract][Full Text] [Related]
14. Increased Expression of the Receptor for Advanced Glycation End-Products (RAGE) Is Associated with Advanced Breast Cancer Stage.
Nankali M; Karimi J; Goodarzi MT; Saidijam M; Khodadadi I; Razavi AN; Rahimi F
Oncol Res Treat; 2016; 39(10):622-628. PubMed ID: 27710974
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
16. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
18. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.
Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG
Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
[TBL] [Abstract][Full Text] [Related]
20. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
